Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Molecular Biomarkers in Advanced Prostate Cancer: Translation to the Clinic.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2016

Beltran Himisha, Antonarakis Emmanuel S, Morris Michael J, Attard Gerhardt

Abstract excerpt

Recent clinical and preclinical studies focused on understanding the molecular landscape of castration-resistant prostate cancer (CRPC) have provided insights into mechanisms of treatment resistance, disease heterogeneity, and potential therapeutic targets. This work has served as a framework for several ongoing clinical studies focused on bringing novel observations into the clinic in the form of tissue, liquid,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplastic Cells, Circulating
Share to Oncogene Proteins, Fusion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phthalazines

Share to Poly (ADP-Ribose) Polymerase-1

Share to Prostatic Neoplasms, Castration-Resistant

Share to Receptors, Androgen

Share to Transcriptional Regulator ERG

Share to Translational Research, Biomedical

Source

Identifiers

PMID: 27249694
DOI: 10.1200/EDBK_159248

Genes

FGFR2
PARP1
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Molecular Biomarkers in Advanced Prostate Cancer: Translation to the Clinic.PMID 27249694Read ↗

Contemporary molecular tests for prognosis and treatment guidance for castration-resistant prostate cancer.Semantic proximity Read ↗

Emerging Biomarker-Guided Therapies in Prostate CancerSemantic proximity Read ↗

Molecular landscape of prostate cancer: Implications for current clinical trialsSemantic proximity Read ↗

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic FrontiersSemantic proximity Read ↗

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity Read ↗

Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.Semantic proximity Read ↗

Future directions for precision oncology in prostate cancerSemantic proximity Read ↗

Clinical implications of genomic alterations in metastatic prostate cancer.Semantic proximity Read ↗

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision MakingSemantic proximity Read ↗

Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancerSemantic proximity Read ↗

Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting TherapiesSemantic proximity Read ↗

De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.